Sales Force Downsizing By Big Pharma Means Small/Mid-Tier Boom, CSOs Say
Sales force restructuring among large pharmaceutical companies is helping to drive contract sales agreements with small and mid-tier companies, contract sales organizations say
You may also be interested in...
GlaxoSmithKline will reduce the size of its sales force and reinvest those expenditures in research and development should Pfizer decide to downsize its sales team, GSK CEO J.P. Garnier said
AstraZeneca CEO Tom McKillop called on the pharmaceutical industry to reduce the costs associated with selling and marketing drugs, but does not believe his company will be the catalyst for change
AstraZeneca's decision to reduce the number of contract sales reps may be an early indicator of an industry trend in 2005